Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion type Assertion NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_head.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion description "[Clinical trials carried out during the past decade have proved that CGRP receptor antagonists are effective for treating migraine, and antibodies to the receptor and CGRP are currently under investigation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_provenance.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion evidence source_evidence_literature NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_provenance.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion SIO_000772 25340934 NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_provenance.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion wasDerivedFrom befree-2016 NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_provenance.
- NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_assertion wasGeneratedBy ECO_0000203 NP1232115.RAB9gwb5kmxm7MtfkOas0-2sAlU_U5YXb1XyrMPyxtKnc130_provenance.